Two Sigma Securities’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,195
| Closed | -$60.8K | – | 2021 |
|
|
2023
Q4 | $60.8K | Buy |
+4,195
| New | +$60.8K | ﹤0.01% | 1019 |
|
|
2023
Q2 | – | Sell |
-2,881
| Closed | -$38K | – | 1784 |
|
|
2023
Q1 | $38K | Buy |
+2,881
| New | +$38K | ﹤0.01% | 1000 |
|
|
2022
Q3 | – | Sell |
-3,647
| Closed | -$41K | – | 1816 |
|
|
2022
Q2 | $41K | Buy |
+3,647
| New | +$41K | ﹤0.01% | 912 |
|
|
2020
Q3 | – | Sell |
-3,721
| Closed | -$68K | – | 880 |
|
|
2020
Q2 | $68K | Buy |
+3,721
| New | +$68K | ﹤0.01% | 467 |
|
|
2019
Q2 | – | Sell |
-1,581
| Closed | -$41K | – | 1273 |
|
|
2019
Q1 | $41K | Sell |
1,581
-942
| -37% | -$24.4K | ﹤0.01% | 674 |
|
|
2018
Q4 | $58K | Sell |
2,523
-1,081
| -30% | -$24.9K | ﹤0.01% | 971 |
|
|
2018
Q3 | $116K | Buy |
+3,604
| New | +$116K | ﹤0.01% | 915 |
|
|
2017
Q1 | – | Sell |
-1,470
| Closed | -$35K | – | 1088 |
|
|
2016
Q4 | $35K | Buy |
+1,470
| New | +$35K | 0.01% | 623 |
|